Cargando…
TRIM37 promotes tumor cell proliferation and drug resistance in pediatric osteosarcoma
Osteosarcoma (OS) is among the most frequently occurring bone tumors, particularly in children. Clinical treatment of OS is limited due to several factors including resistance to chemotherapy drugs and metastasis, and the underlying molecular mechanisms remain unclear. In the present study, triparti...
Autores principales: | Tao, Yanling, Xin, Meiyun, Cheng, Huanchen, Huang, Zongxuan, Hu, Tiantian, Zhang, Teng, Wang, Jianlong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686442/ https://www.ncbi.nlm.nih.gov/pubmed/29163677 http://dx.doi.org/10.3892/ol.2017.7059 |
Ejemplares similares
-
Knockdown of Tripartite Motif-Containing Protein 37 (TRIM37) Inhibits the Proliferation and Tumorigenesis in Colorectal Cancer Cells
por: Zhao, Ping, et al.
Publicado: (2017) -
TRIM37 promotes epithelial-mesenchymal transition in colorectal cancer
por: Hu, Cheng-En, et al.
Publicado: (2017) -
TRIM14 regulates cell proliferation and invasion in osteosarcoma via promotion of the AKT signaling pathway
por: Xu, Guoxing, et al.
Publicado: (2017) -
TRIM37 promotes gallbladder cancer proliferation by activating the Wnt/β-catenin pathway via ubiquitination of Axin1
por: Xu, Ming, et al.
Publicado: (2023) -
Silencing TRIM37 inhibits the proliferation and migration of non-small cell lung cancer cells
por: Ding, Yi, et al.
Publicado: (2018)